跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EMBLAVEO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1.5G/0.5G - HSA Drug Approval Details
Approvals
/
HSA
/
EMBLAVEO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1.5G/0.5G
Approved
THERAPEUTIC
EMBLAVEO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1.5G/0.5G
Hospira Australia Pty Ltd (AUSTRALIA)
🇸🇬 Health Sciences Authority
Approval Date
Jan 15, 2026
Approval ID
e90e96fb3ef53136
Company
Hospira Australia Pty Ltd (AUSTRALIA)
Type
Therapeutic
Approval Details
Approval Id
e90e96fb3ef53136
Drug Name
EMBLAVEO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1.5G/0.5G
Product Name
EMBLAVEO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1.5G/0.5G
Approval Number
SIN17438P
Approval Date
2026-01-15
Registrant
PFIZER PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 15, 2026
Approval ID
e90e96fb3ef53136
Type
Therapeutic
Back to HSA Approvals